Small-molecule modulators of tumor necrosis factor signaling
Research output: Contribution to journal › Review › Research › peer-review
Documents
- Fulltext
Final published version, 1.6 MB, PDF document
Tumor necrosis factor (TNF) is a pleiotropic cytokine with a major role in immune system homeostasis and is involved in many inflammatory and autoimmune diseases, such as rheumatoid arthritis (RA), psoriasis, Alzheimer's disease (AD), and multiple sclerosis (MS). Thus, TNF and its receptors, TNFR1 and TNFR2, are relevant pharmacological targets. Biologics have been developed to block TNF-dependent signaling cascades, but they display serious side effects, and their pharmacological effectiveness decreases over time because of their immunogenicity. In this review, we present recent discoveries in small molecules targeting TNF and its receptors and discuss alternative strategies for modulating TNF signaling.
Original language | English |
---|---|
Article number | 103575 |
Journal | Drug Discovery Today |
Volume | 28 |
Issue number | 6 |
ISSN | 1359-6446 |
DOIs | |
Publication status | Published - 2023 |
Bibliographical note
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 341791263